🔓
Sign in as a Member to unlock the full view of COR. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$24.50/mo already a Member? Sign in →
GovGreed
COR

Cencora, Inc.

Sector: healthcareMedical - DistributionNYSEMarket Cap: $70.24B

Cencora is a global pharmaceutical sourcing and distribution company with a significant political signal from concentrated congressional selling, where one member executed 6 sales totaling up to $675K in the last 12 months.

Govt Dependence
5/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
BEARISH

BusinessWhat COR does

Cencora operates as a pharmaceutical wholesale and distribution company, connecting manufacturers with healthcare providers. Its revenue is derived from drug distribution, specialty pharmacy, and consulting services. The company's model is heavily exposed to pharmaceutical supply chain regulation and reimbursement policies.

12 months past · 3 months futureCOR activity timeline

$386$328$270 JunJulAugSepOctNovDecJan '26FebMarAprMayJunJulAug ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · May 18 $374.75 hi $278.40 lo $304.00 CONGRESS 30 INSIDERS 0 13F FUNDS 0 BILLS 41 Jared Moskowitz (D) · Purchase · 2026-03-23Jared Moskowitz (D) · Purchase · 2026-03-31Ro Khanna (D) · Purchase · 2026-01-29Michael T. McCaul (R) · sale · 2025-10-27Michael T. McCaul (R) · Sale · 2025-10-27Michael T. McCaul (R) · sale · 2025-08-07Michael T. McCaul (R) · sale · 2025-08-22Michael T. McCaul (R) · Sale · 2025-08-22Michael T. McCaul (R) · Sale · 2025-08-07Michael T. McCaul (R) · Sale · 2025-06-27Michael T. McCaul (R) · sale · 2025-06-27 S.827 · markup · 2025-07-30HR.1860 · committee · 2025-09-16HR.2068 · committee · 2025-06-12 MARKUP · House Appropriations Subcommittee on Department of Homeland · 2026-05-18MARKUP · Senate Appropriations Subcommittee on Commerce, Justice, Sci · 2026-05-19MARKUP · Senate Appropriations Subcommittee on Departments of Labor, · 2026-05-19MARKUP · Senate Appropriations Subcommittee on Department of Defense · 2026-05-19MARKUP · House Appropriations Subcommittee on Commerce, Justice, Scie · 2026-05-19MARKUP · Senate Appropriations Subcommittee on Transportation, Housin · 2026-05-19MARKUP · Senate Budget · 2026-05-20MARKUP · Senate Health, Education, Labor, and Pensions · 2026-05-20MARKUP · House Education and Workforce Subcommittee on Health, Employ · 2026-05-20MARKUP · House Energy and Commerce Subcommittee on Oversight and Inve · 2026-05-20MARKUP · House Energy and Commerce Subcommittee on Health · 2026-05-20MARKUP · Senate Appropriations Subcommittee on Energy and Water Devel · 2026-05-20MARKUP · Senate Veterans' Affairs · 2026-05-20MARKUP · Senate Health, Education, Labor, and Pensions · 2026-05-21MARKUP · Senate Appropriations Subcommittee on Department of Defense · 2026-05-21MARKUP · House Appropriations Subcommittee on Departments of Transpor · 2026-05-21
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) carveout (this ticker)
240 trading days · 11 congressional trades shown · 0 insider buys · 0 13F filings · 3 past bill actions · 16 upcoming markups

Lifetime Government AwardsCOR federal contracts

COR doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Politicians Trading CORMembers of Congress with recent COR positions

5 politicians traded COR across 37 disclosed transactions totaling $1.7M (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just COR). 0-30 LOW · 30-60 MID · 60+ HIGH.

Congressional TradesWho in Congress is trading COR

2026-03-23 Jared Moskowitz D-Florida · house Purchase $1,001 - $15,000
2026-03-31 Jared Moskowitz D-Florida · house Purchase $1,001 - $15,000
2026-01-29 Ro Khanna D-California · house Purchase $1,001 - $15,000
2025-10-27 Michael T. McCaul R-Texas · house sale $15,001 - $50,000
2025-10-27 Michael T. McCaul R-Texas · house Sale $15,001 - $50,000
2025-08-07 Michael T. McCaul R-Texas · house sale $50,001 - $100,000
2025-08-22 Michael T. McCaul R-Texas · house sale $50,001 - $100,000
2025-08-22 Michael T. McCaul R-Texas · house Sale $50,001 - $100,000
2025-08-07 Michael T. McCaul R-Texas · house Sale $50,001 - $100,000
2025-06-27 Michael T. McCaul R-Texas · house Sale $100,001 - $250,000
2025-06-27 Michael T. McCaul R-Texas · house sale $100,001 - $250,000
2025-05-12 Jefferson Shreve R-Indiana · house sale $50,001 - $100,000
30+ trades on file · most recent 2026-04-30

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

12
stock awards · $2.1M market value
2026-03-05 DURCAN DERMOT MARK Director AWARD 905 sh $325K
2026-03-05 Clyburn Frank Director AWARD 557 sh $200K
2026-03-05 Baumann Werner Director AWARD 557 sh $200K
2026-03-05 NALLY DENNIS M Director AWARD 557 sh $200K
2026-03-05 Miller Redonda Director AWARD 557 sh $200K
2026-03-05 Kim Lorence H. Director AWARD 557 sh $200K
2026-03-05 Tyler Lauren M Director AWARD 557 sh $200K
2026-03-05 Cooper Ellen Director AWARD 557 sh $200K
For COR, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting CORLive legislation impacting this stock

Political ProfileWhere COR sits in Washington

[object Object]

STRUCTURAL: High regulatory density (score: 85) from 8 active healthcare bills. EVIDENTIARY: Concentrated, high-value selling by a single congressman (Rep. McCaul, up to $675K across 6 sales) and a separate sale by Rep. Slotkin; only one small buy offsets. Net: Evidentiary selling pressure dominates a neutral structural backdrop.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • Heightened legislative scrutiny on pharmaceutical supply chains and pricing.
    U.S. Congress
    "8 recent healthcare bills with non-zero estimated revenue impact from `Recent bill_impacts`."

Regulatory opportunities

  • No specific regulatory opportunities flagged.

Capitol Hill AlliesChampions & critics

Congressional champions

Congressional critics

Member intelligence layer

Live signals + predictions for COR — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $24.50/mo Locked rate forever · cancel anytime

Frequently AskedAbout COR & political exposure

Does Cencora, Inc. (COR) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Cencora, Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Has Congress traded COR stock?
51 congressional trades by 7 unique members of Congress, most recently on 2026-03-31. See the Congressional Trading panel for politician-by-politician breakdown.
What is COR political risk profile?
Government dependence: 5/100. Lobbying intensity: 0/100. Political signal: bearish. Donor party split: R 0% / D 0%.
How does GovGreed track COR political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. COR data is updated daily from these official federal sources.